products

API Anti Inflammatory Medicine Dex Budesonide CAS 51372-29-3 99.5% Purity

Basic Information
Place of Origin: China
Brand Name: Senwayer Brand
Certification: ISO, 9001, USP
Model Number: 51372-29-3
Minimum Order Quantity: 10grams
Price: Discount is possible if your order is big enough
Packaging Details: 10g, 20g, 50g , 100g, 500g. 1kg, 10kg
Delivery Time: within 2 working days
Payment Terms: T/T in advance, Money Gram, Western Union, Bank Transfer.
Supply Ability: 1000kg/month
Detail Information
CAS: 51372-29-3 Alias: Budesonide , Dexbudesonide
Apparence: Almost White Crystalline Powder Purity: 99.5%
Stock: Enough Stock COA: Available
High Light:

anti inflammatory medications

,

anti allergy medicine


Product Description

Medical API Budesonide Dexbudesonide Anti AllergicCAS CAS 51372-29-3 White Powder

 

Quick detail


Chemical Name:Budesonide
16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxypregna-1,4-diene-3,20-dione
Cas No.:51372-29-3
Molecular Structure:
Molecular Formula:C25H34O6
Molecular Weight:430.53
Important Specifications

Standard:In-house Standard

Appearance: white or almost white
Assay:≥98%
Packing:15 10kg/Alu foil bag

 

Budesonide​ Introduction


Budesonide​ medication is used to treat certain bowel conditions (such as Crohn's disease,ulcerative colitis). While budesonide does not cure these conditions, it may decrease symptoms such as pain and diarrhea. Budesonide is an anti-inflammatory drug (corticosteroid hormone). It works by decreasing the body's natural defense response (immune response).

 

How should I take budesonide?


Read the Patient Information Leaflet provided by your pharmacist before you start using budesonide and each time you get a refill. If you have any questions, consult your doctor or pharmacist.

 

Take this medication by mouth with or without food as directed by your doctor, usually once daily in the morning. Take this medication by mouth with a full glass of water (8 ounces/240 milliliters) unless your doctor directs you otherwise. Swallow this medication whole. Do not crush or chew.

 

Doing so can release all of the drug at once, increasing the risk of side effects. If you are using the extended-release tablets, do not split the tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing.

The dosage and length of treatment are based on your medical condition, response to treatment, and age.

 

Budesonide dosing information


1. Usual Adult Dose for maintenance treatment of asthma as prophylactic therapy.
Initial dose: 360 mcg via oral inhalation twice a day: in some patients an initial dose of 180 mcg twice a day may be adequate
Maintenance dose: May increase dose in 1 to 2 weeks if response is not adequate; after asthma stability has been achieved, titrate to the lowest effective dose to reduce the possibility of side effects
Maximum dose: 720 mcg twice a day
2. Usual Adult Dose for Crohn's Disease -- Acute: Use: Treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon
Initial dose: 9 mg orally once a day in the morning for up to 8 weeks
-May repeat course for recurring episodes of active disease
3.  Use: Treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon
 
Initial dose: 9 mg orally once a day in the morning for up to 8 weeks
 4.  Usual Adult Dose for Crohn's Disease -- Maintenance:
Enteric coated capsules:
6 mg orally once a day in the morning for up to 3 months
-If symptom control is maintained at 3 months, attempt to taper to complete cessation
Use: Maintenance of clinical remission of mild to moderate Crohn's disease involving the ileum and/or the ascending colon for up to 3 months.
5. Usual Adult Dose for Ulcerative Colitis:
Extended-release tablets:
Initial dose: 9 mg orally once a day in the morning
Duration of therapy: Up to 8 weeks
6. Rectal Foam:
For Active Mild to Moderate Distal Ulcerative Colitis Extending up to 40 cm from the Anal Verge:
1 metered dose administered rectally twice a day for 2 weeks, then 1 metered dose administered rectally once a day for 4 weeks

Use: For the induction of remission in patients with active, mild to moderate ulcerative colitis.

​​

Interactions


Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist.

Do not start, stop, or change the dosage of any medicines without your doctor's approval.

 

API Anti Inflammatory Medicine Dex Budesonide CAS 51372-29-3 99.5% Purity 0

Contact Details
senwayer

WhatsApp : +8617764031156